Elevated circulating bile acids driven erythrocyte osmotic resistance marks hepatobiliary disease
American Journal of Physiology-Gastrointestinal and Liver Physiology · 01.08.2026 · 331 (2) · G262-G276
DOI: 10.1152/ajpgi.00096.2026 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Gastrointestinal and Liver Physiology, erschienen am 01.08.2026. Verfasst von Beng San Yeoh und 7 weiteren Autor:innen. Beteiligte Einrichtung: UT Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United…. Hauptthemen laut MEDLINE: Bile Acids and Salts, Erythrocytes, Liver Diseases. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Crohn's and Colitis Foundation (CCF), NCI NIH HHS, American Heart Association (AHA).
Abstract (Originalsprache)
Elevated circulating bile acids are associated with increased red blood cell (RBC) resistance to osmotic hemolysis in mice and humans. This phenotype reflects bile acid-driven remodeling of RBC membranes and provides a basis for a whole blood assay to assess cholemia using small blood volumes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- UT Microbiome Consortium, Department of Physiology and Pharmacology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio, United States.
- Center for Inflammation, Immunity and Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, Georgia, United States.
- Division of Gastroenterology and Hepatology, University of Toledo Medical Center, Toledo, Ohio, United States.
- Department of Food Science, Purdue University, West Lafayette, Indiana, United States.
ORCID-Profile: Beng San Yeoh, Bina Joe, Thomas Sodeman, Matam Vijay-Kumar
Förderung
- Crohn's and Colitis Foundation (CCF)
- NCI NIH HHS
- American Heart Association (AHA)
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- NIDDK NIH HHS
- American Liver Foundation (ALF)
- HHS | NIH | National Cancer Institute
Zitieren
APA
Yeoh, B. S., Sah, S. K., Saha, P., Joe, B., Gewirtz, A. T., Sodeman, T., Reddivari, L., & Vijay-Kumar, M. (2026). Elevated circulating bile acids driven erythrocyte osmotic resistance marks hepatobiliary disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 331(2), G262-G276. https://doi.org/10.1152/ajpgi.00096.2026
Vancouver
Yeoh BS, Sah SK, Saha P, Joe B, Gewirtz AT, Sodeman T, et al. Elevated circulating bile acids driven erythrocyte osmotic resistance marks hepatobiliary disease. American Journal of Physiology-Gastrointestinal and Liver Physiology. 2026;331(2):G262-G276. doi:10.1152/ajpgi.00096.2026
BibTeX
@article{Yeoh2026,
author = {Yeoh, Beng San and Sah, Sadhana K and Saha, Piu and Joe, Bina and Gewirtz, Andrew T and Sodeman, Thomas and Reddivari, Lavanya and Vijay-Kumar, Matam},
title = {Elevated circulating bile acids driven erythrocyte osmotic resistance marks hepatobiliary disease},
journal = {American Journal of Physiology-Gastrointestinal and Liver Physiology},
year = {2026},
volume = {331},
number = {2},
pages = {G262--G276},
doi = {10.1152/ajpgi.00096.2026}
}
EUVIMED